Likely active: portfolio news Nov 2026 Verified 7 Nov 2026
415 Capital
Munich-based specialist MedTech venture capital firm that invests in clinical through commercial stage medical device companies, focused on cardiovascular and neurovascular disease, across Europe, Israel and North America.
- Type
- VC firm
- Location
- Munich, Germany
- Stages
- Series A, Series B, Growth
- Sectors
- Healthtech and life sciences, Medtech
- Fund size / AUM
- EUR 150 Million second fund (own site news)
- Website
- 415capital.com
Contacts on file
For 415 Capital, the paid file holds: 5 named decision-makers with roles; firm contact email (domain checked); check size; how to pitch (the route the firm publishes); LinkedIn page.
Get Europe Complete, $99 Free sample
One-time payment. No subscription. No account.
Notable investments
Supira MedicalLaza MedicalEndovascular EngineeringReEmergeVesper Medical
Sources
- 415capital.com/
- 415capital.com/about/
- 415capital.com/team/
- 415capital.com/news/
- 415capital.com/investments/
- registers.esma.europa.eu/publication/searchRegister?core=esma_registers_funds
Last checked 7 Nov 2026. Is something wrong? Tell us.
Appears in 20 lists
Medtech investors in Europe (45)Venture capital firms in Germany (56)Series B medtech investors (57)Startup investors in Germany (91)Growth-stage medtech investors (107)Series B investors in Europe (117)Series A medtech investors (125)Series B healthtech investors (160)Growth-stage investors in Europe (276)Healthtech investors in Europe (291)Growth-stage healthtech investors (316)Series A investors in Europe (329)Series B investors (339)Series A healthtech investors (401)Venture capital firms in Europe (412)Medtech investors (457)Growth-stage investors (705)Startup investors in Europe (725)Series A investors (864)Healthtech investors (1,207)